FDA Approves Oral Azacitidine for Acute Myeloid Leukemia

·

·

FDA Approves Oral Azacitidine for Acute Myeloid Leukemia

2020-09-01 20:38:00. Sara Karlovitch, Assistant Editor. The FDA has approved 300 mg tablets of azacitidine (Onureg, Bristol Myers Squibb) for the continued treatment of adult patients with acute myeloid leukemia (AML) who achieved first complete remission …
See Original Article

How Healist's natural blends work with CBD to promote sleep

Thanks to years of cannabis prohibition, it can be easy to think of CBD and other hemp products as just another way to knock yourself out, like a glass of wine or a sleeping pill. On the contrary: Hemp and other natural ingredients, like those in Healist’s sleep …
See Original Article

Reopening NJ indoor dining brings hope to Borgata furloughed employees

ATLANTIC CITY, N.J. – Another sign of the economic pain being caused by COVID-19 are furloughs for thousands of employees at the Borgata in Atlantic City are now permanent. But, there’s some hope as indoor dining is set to resume in New Jersey on …
See Original Article

Avid Bioservices: Fiscal 1Q Earnings Snapshot

TUSTIN, Calif. (AP) — Avid Bioservices Inc. (CDMO) on Tuesday reported fiscal first-quarter net income of $4.7 million, after reporting a loss in the same period a year earlier. On a per-share basis, the Tustin, California-based company said it had profit of 6 …
See Original Article

Report: Job Growth In Next Decade Predicted Slower Than Great Recession

U.S. employment is projected to increase by 6 million jobs over the decade from 2019 through 2029. But the annual growth rate is slower than during the economy’s recovery from the Great Recession, according to U.S. Bureau of Labor Statistics (BLS).
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.